Literature DB >> 14598291

Myelin-associated inhibitors of axon regeneration.

Edith M Grados-Munro1, Alyson E Fournier.   

Abstract

Trauma in the adult mammalian central nervous system (CNS) has devastating clinical consequences due to the failure of injured axons to spontaneously regenerate. Over 20 years ago, pioneering work demonstrated that the non-permissive nature of CNS myelin for axon outgrowth contributes to this regenerative failure. Over the past few years, tremendous progress has been made in our understanding of the inhibitory components of CNS myelin, the axonal receptors that respond to these cues, and the intracellular signaling cascades mediating axon outgrowth inhibition. Several approaches designed to antagonize molecular mediators of axon inhibition have been tested in an effort to promote regenerative growth after CNS injury. These studies have validated the role of many candidate proteins in axon outgrowth inhibition; however, other approaches such as the generation of knockout mice for myelin-associated inhibitors have created new questions in the field. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14598291     DOI: 10.1002/jnr.10803

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  18 in total

Review 1.  Can regenerating axons recapitulate developmental guidance during recovery from spinal cord injury?

Authors:  Noam Y Harel; Stephen M Strittmatter
Journal:  Nat Rev Neurosci       Date:  2006-08       Impact factor: 34.870

2.  Expression of transcripts for myelination-related genes in the anterior cingulate cortex in schizophrenia.

Authors:  Robert E McCullumsmith; Daya Gupta; Monica Beneyto; Emily Kreger; Vahram Haroutunian; Kenneth L Davis; James H Meador-Woodruff
Journal:  Schizophr Res       Date:  2007-01-12       Impact factor: 4.939

3.  Anti-ganglioside antibody-mediated activation of RhoA induces inhibition of neurite outgrowth.

Authors:  Gang Zhang; Helmar C Lehmann; Sowmia Manoharan; Mohammedali Hashmi; Sangwoo Shim; Guo-Li Ming; Ronald L Schnaar; Pablo H Lopez; Nataliia Bogdanova; Kazim A Sheikh
Journal:  J Neurosci       Date:  2011-02-02       Impact factor: 6.167

4.  Selective temporal and regional alterations of Nogo-A and small proline-rich repeat protein 1A (SPRR1A) but not Nogo-66 receptor (NgR) occur following traumatic brain injury in the rat.

Authors:  Niklas Marklund; Carl T Fulp; Saori Shimizu; Rishi Puri; Asenia McMillan; Stephen M Strittmatter; Tracy K McIntosh
Journal:  Exp Neurol       Date:  2006-01       Impact factor: 5.330

5.  Antigen-specific therapy promotes repair of myelin and axonal damage in established EAE.

Authors:  Chunhe Wang; Bruce G Gold; Laurie J Kaler; Xiaolin Yu; Michael E Afentoulis; Gregory G Burrows; Arthur A Vandenbark; Dennis N Bourdette; Halina Offner
Journal:  J Neurochem       Date:  2006-08-03       Impact factor: 5.372

6.  Expression of PirB protein in intact and injured optic nerve and retina of mice.

Authors:  Xiaofeng Cai; Rongdi Yuan; Zheng Hu; Chunlin Chen; Jun Yu; Zheng Zheng; Jian Ye
Journal:  Neurochem Res       Date:  2011-11-19       Impact factor: 3.996

Review 7.  Neurodegeneration and cell replacement.

Authors:  Brandi K Ormerod; Theo D Palmer; Maeve A Caldwell
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-01-12       Impact factor: 6.237

Review 8.  Plasticity and stability of visual field maps in adult primary visual cortex.

Authors:  Brian A Wandell; Stelios M Smirnakis
Journal:  Nat Rev Neurosci       Date:  2009-11-11       Impact factor: 34.870

Review 9.  Role of electrical stimulation for rehabilitation and regeneration after spinal cord injury: an overview.

Authors:  Samar Hamid; Ray Hayek
Journal:  Eur Spine J       Date:  2008-08-02       Impact factor: 3.134

10.  Rolipram-induced elevation of cAMP or chondroitinase ABC breakdown of inhibitory proteoglycans in the extracellular matrix promotes peripheral nerve regeneration.

Authors:  E Udina; A Ladak; M Furey; T Brushart; N Tyreman; T Gordon
Journal:  Exp Neurol       Date:  2009-09-04       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.